Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S16 pseudogene 8 (RPS16P8), also known as RPS16_4_1529, is classified as a processed pseudogene derived from the functional gene that encodes ribosomal protein S16[2][3][5]. Like other ribosomal protein pseudogenes, RPS16P8 arose from reverse transcription and insertion of mRNA and is an intronless, nonfunctional copy dispersed in the genome[2][3][5]. The parent gene, RPS16, encodes a component of the 40S ribosomal subunit, which is essential for protein synthesis[6]. However, RPS16P8 and other S16 pseudogenes do not encode functional proteins and are not involved in protein synthesis, cellular signaling, or disease processes[2][3][5]. There is no evidence that RPS16P8 plays a biological role, participates in disease, or serves as a biomarker or drug target[2][3][5]. Note: While some pseudogenes can be transcribed or have regulatory functions in rare cases, there is no data supporting such a role for RPS16P8; it is classified as an inactive, processed pseudogene in current gene catalogs[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S16 pseudogene 8 (RPS16P8).